Sg3 Management, LLC Agios Pharmaceuticals, Inc. Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $266,800 - $348,100	-10,000 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$29.58 - $49.78 $591,600 - $995,600	-20,000 Reduced 66.67%	10,000 $329,000
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $628,800 - $872,700	15,000 Added 100.0%	30,000 $1.39 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $1.82 Million - $2.14 Million	-35,000 Reduced 70.0%	15,000 $827,000
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $1.55 Million - $2.01 Million	35,000 Added 233.33%	50,000 $2.58 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $498,150 - $698,100	15,000 New	15,000 $650,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.